GARMASTAN Trademark

Trademark Overview


On Friday, December 8, 2023, a trademark application was filed for GARMASTAN with the United States Patent and Trademark Office. The USPTO has given the GARMASTAN trademark a serial number of 79386640. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, December 11, 2024. This trademark is owned by PROTINA Pharmazeutische Gesellschaft mbH. The GARMASTAN trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations, namely mineral and vitamin preparations for medical use; pharmaceutical preparations for the treatment of disorders of the immune system and for strengthening of the immune system, sanitary preparations for medical use; medicines; dietetic preparations adapted for medical use; nutritional supplements adapted for medical and for non-medical use; nutritional supplements adapted for medical and for non-medical use, namely, alkaline supplements; food for babies, medical plasters

Cosmetics, non-medicated ointments for skin care; non-medicated nipple ointments for breastfeeding mothers
garmastan

General Information


Serial Number79386640
Word MarkGARMASTAN
Filing DateFriday, December 8, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, December 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely mineral and vitamin preparations for medical use; pharmaceutical preparations for the treatment of disorders of the immune system and for strengthening of the immune system, sanitary preparations for medical use; medicines; dietetic preparations adapted for medical use; nutritional supplements adapted for medical and for non-medical use; nutritional supplements adapted for medical and for non-medical use, namely, alkaline supplements; food for babies, medical plasters
Goods and ServicesCosmetics, non-medicated ointments for skin care; non-medicated nipple ointments for breastfeeding mothers

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 30, 2023
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePROTINA Pharmazeutische Gesellschaft mbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events


Event DateEvent Description
Thursday, December 28, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Saturday, December 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 3, 2024APPLICATION FILING RECEIPT MAILED
Monday, July 8, 2024ASSIGNED TO EXAMINER
Wednesday, July 10, 2024NON-FINAL ACTION WRITTEN
Thursday, July 11, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 1, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 1, 2024REFUSAL PROCESSED BY MPU
Saturday, August 24, 2024REFUSAL PROCESSED BY IB
Wednesday, December 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED